Leverage public data to benchmark trials, optimize enrollment, and accelerate market access.
Speed and efficiency decide who wins in the race to market. A few months of delay in clinical trials doesn’t just mean millions in lost revenue – it also eats into valuable patent exclusivity time. Since companies file patents years before launch, every delay shortens the window to maximize market share before generics or biosimilars enter the scene. So, how do you know if your R&D processes are keeping up?
Most pharma companies measure success by looking backward, comparing it against their own past performance. That’s useful, but it’s not enough. To stay ahead, you need to see where you stand against industry peers.
Publicly available clinical trial data makes that possible. With Planisware, you can track real-time industry benchmarks—without leaving your workflow.
Why Real-Time Benchmarking Matters
Every pharma company wants to bring life-changing treatments to patients fast. But clinical trials take time, cost money, and hit roadblocks. Here’s what you’re up against.
80% of trials miss their recruitment targets according to the NIH because sites overestimate patient numbers or lose participants.
Mid-stage trials take 18 months to enroll patients. AI-driven site selection cuts that time in half, saving months of delays.
Regulatory submissions drag on for 10 months. But data-driven optimization shaves off weeks—or even months—getting drugs approved faster.
Planisware Turns Public Data into a Competitive Advantage
Planisware links to https://clinicaltrials.gov/, so you get instant industry comparisons—no manual research, no wasted time.
Image
Predicting Clinical Trial Duration for Diabetes Using Public Data in Planisware
What This Means for You
Make Faster, Smarter Calls – No more guesswork. See real-time industry data instead of relying on old benchmarks.
Stay Ahead – If competitors hit Phase 2 in 18 months but you take two years, you’ll spot the gap— and adjust your strategy to close it.
Sharpen Your Strategy – Choose the right sites, tweak protocols, and use resources wisely with real-world insights.
Smarter Enrollment Strategies Will Keep Your Trials on Track
Recruitment delays slow down trials. But public data shows where competitors succeed or struggle. With Planisware’s intuitive dashboard, you can;
Find top-performing trial sites before making decisions.
Spot enrollment roadblocks early and adjust before delays hit.
See how your enrollment speed compares to industry benchmarks.
Refine recruitment strategies in real time to stay ahead of the curve.
Image
Planisware Studies Duration Comparison Against clinicaltrial.gov
Speed Wins the Market—Are You Getting Ahead or Falling Behind?
The first drug to market usually dominates. Once doctors prescribe a medication, they rarely switch unless there has been an adverse reaction, or the patient is not responding to the treatment as expected. That’s why speed is everything.
If a competitor is six months ahead, you need to adjust now—before it’s too late.
If you’re neck and neck, focus on differentiation to maximize market share.
With Planisware’s built-in benchmarking, you don’t just track progress—you see exactly where you stand in the industry.
How Pharma Leaders Use AI to Speed Up Trials
AI and real-world data are transforming clinical trials. Pharma companies are using these technologies to find patients faster, optimize site selection, and reduce delays—giving them a competitive edge.
You can do the same. By combining publicly available clinical trial data with AI-driven insights, you can accelerate recruitment, improve efficiency, and bring therapies to market faster. Here’s how leading drugmakers are already leveraging AI:
Amgen’s ATOMIC AI scans billions of records to find the best trial sites—cutting patient enrollment time for mid-stage studies by 50%.
Novartis speeds up enrollment with AI. Instead of waiting months, they scan real-world data to find qualified patients faster. Enrollment times dropped 10% to 15%, cutting costs and boosting approval chances.
Bayer slashes trial costs with AI. In a late-stage study for asundexian (a stroke prevention drug), AI replaced placebo groups with real-world data, cutting thousands of participants, saving millions, and reducing recruitment time by nine months.
With Planisware’s built-in benchmarking, you can apply AI-driven insights and keep your trials ahead.
From Good to Great - Why Benchmarking Matters
Measuring progress internally is easy. But without external benchmarks, how do you know if you're ahead of the industry—or trailing behind?
With Planisware’s public data integration, you can;
Spot blind spots. See exactly where you lead, or lag compared to peers.
Use resources wisely. Invest where it drives efficiency and removes bottlenecks.
Plan smarter. Make data-driven moves that speed up time to market.
Stop guessing. Start knowing. With real-time benchmarking, Planisware gives you unmatched visibility into your industry standing—so you can lead, not follow.
